- Home
- STTK vs CCLD Comparison
STTK vs CCLD Comparison
Compare STTK & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- CCLD
- Stock Information
- Founded
- STTK 2016
- CCLD 1999
- Country
- STTK United States
- CCLD United States
- Employees
- STTK N/A
- CCLD N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- STTK Health Care
- CCLD Technology
- Exchange
- STTK Nasdaq
- CCLD Nasdaq
- Market Cap
- STTK 56.8M
- CCLD 66.3M
- IPO Year
- STTK 2020
- CCLD 2014
- Fundamental
- Price
- STTK $1.37
- CCLD $3.57
- Analyst Decision
- STTK Hold
- CCLD Strong Buy
- Analyst Count
- STTK 3
- CCLD 2
- Target Price
- STTK $2.00
- CCLD $3.75
- AVG Volume (30 Days)
- STTK 131.9K
- CCLD 116.0K
- Earning Date
- STTK 03-03-2025
- CCLD 03-20-2025
- Dividend Yield
- STTK N/A
- CCLD N/A
- EPS Growth
- STTK N/A
- CCLD N/A
- EPS
- STTK N/A
- CCLD N/A
- Revenue
- STTK $6,435,000.00
- CCLD $111,014,000.00
- Revenue This Year
- STTK $313.04
- CCLD N/A
- Revenue Next Year
- STTK N/A
- CCLD $1.47
- P/E Ratio
- STTK N/A
- CCLD N/A
- Revenue Growth
- STTK 382.75
- CCLD N/A
- 52 Week Low
- STTK $0.94
- CCLD $1.01
- 52 Week High
- STTK $11.76
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- STTK 60.23
- CCLD 45.17
- Support Level
- STTK $1.21
- CCLD $3.90
- Resistance Level
- STTK $1.36
- CCLD $4.75
- Average True Range (ATR)
- STTK 0.10
- CCLD 0.33
- MACD
- STTK 0.01
- CCLD -0.06
- Stochastic Oscillator
- STTK 90.00
- CCLD 17.48
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.